Gastroepiploic vascularized lymph node transfer for the treatment of extremity lymphedema: comparison between middle and distal inset.

Gland surgery 2020 Vol.9(2) p. 528-538

Manrique OJ, Bustos SS, Kapoor T, Lin J, Ciudad P, Forte AJ, Del Corral G, Mani M, Maruccia M, Terzic A

Abstract

[BACKGROUND] Middle and distal insets of gastroepiploic vascularized lymph node transfer (GE-VLNT) for extremity lymphedema have been described. However, there has been no prior comparison of surgical or patient-reported outcomes between these techniques. We analyzed the outcomes between both insets in patients with extremity lymphedema.

[METHODS] Retrospective review of patients with extremity-lymphedema who underwent GE-VLNT. Two groups were analyzed: middle and distal recipient inset. We analyzed 6-month surgical and patient-reported outcomes using the Lymphedema Life Impact Scale-v2 (LLISv2) and scar satisfaction utilizing the Patient Scar Assessment Questionnaire (PSAQ).

[RESULTS] Between 2017 and 2019, 26 patients with stage II unilateral extremity lymphedema underwent laparoscopically-harvested GE-VLNT (13 distal and 13 middle inset). There were no differences in patient demographics between groups. Mean hospital stay for patients with upper extremity lymphedema was 1.3 4.0 days (P<0.05), and for lower extremity lymphedema was 1.0 4.5 days (P<0.05), middle distal inset, respectively. Mean return to daily activities for patients with upper extremity lymphedema was 13.4 33.4 days (P<0.05), and for lower extremity lymphedema was 16.0 29.5 days (P<0.05), middle distal inset, respectively. Both middle and distal inset showed significant mean excess volume reduction at 6 months postoperatively for both upper and lower extremity lymphedema (upper extremity: middle inset 23.3%, distal inset: 22.0%; lower extremity: middle inset 23.3% and distal inset 13.3%). LLISv2 scores showed improved functional outcomes postoperatively in both upper and lower extremity lymphedema with both insets. Scar satisfaction with appearance and symptoms was higher with middle inset (P<0.05).

[CONCLUSIONS] GE-VLNT is an effective surgical treatment for extremity lymphedema. The middle placement showed shorter hospital stay, early return to work and higher patient satisfaction.

추출된 의학 개체 (NER)

유형영어 표현한국어 / 풀이UMLS CUI출처등장
해부 upper extremity lymphedema scispacy 1
합병증 lymphedema scispacy 1
합병증 scar scispacy 1
합병증 upper extremity scispacy 1
약물 [BACKGROUND] Middle scispacy 1
약물 [RESULTS] scispacy 1
약물 [CONCLUSIONS] GE-VLNT scispacy 1
질환 extremity lymphedema scispacy 1
질환 upper extremity lymphedema was 1.3 4.0 days (P<0.05), and for lower extremity lymphedema was 1.0 4.5 days (P<0.05), middle distal inset, respectively. scispacy 1
질환 upper extremity lymphedema scispacy 1
질환 lower extremity lymphedema C1275454
Lymphedema of lower extremity
scispacy 1
질환 Scar scispacy 1
기타 Gastroepiploic scispacy 1
기타 lymph node scispacy 1
기타 patients scispacy 1
기타 Scale-v2 scispacy 1
기타 Patient Scar scispacy 1
기타 patient scispacy 1